We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Virginia Attorney General Mark Herring led 22 state attorneys general in filing an amicus brief urging the Supreme Court to uphold states’ right to hold drugmakers liable for misleading claims. Read More
The Trump administration’s plan to reduce drug prices smacks of “price controls,” more than 50 medical and conservative advocacy groups said in a letter to the White House Tuesday. Read More
The agency said sponsors intending to market multiple dose combinations should “avoid marketing excessive numbers of combinations whose components exert similar blood pressure effects.” Read More
CMS Administrator Seema Verma said value-based payment “is not a panacea…[but] it is an important part of our strategy to lower drug prices.” Read More
An audit by New York State Comptroller Thomas DiNapoli found that the state’s treatment programs didn’t adequately monitor patients with opioid use disorders to ensure they didn’t receive opioid prescriptions elsewhere. Read More
A federal lawsuit accuses Gilead of deliberately keeping a safer version of its HIV drug Tenofovir disoproxil fumarate (TDF) off the market until patent exclusivity ends for the original. Read More
The legislation would “increase prescription drug competition in U.S. markets, driving down prices and improving the quality of life for patients across the country,” the letter states. Read More